Sign InSummary
T2 Biosystems (TTOO) is a company specializing in in vitro diagnostics tools, but its poor financial health, upcoming stock split, and high volatility make it a high-risk stock that is currently evaluated as Hold.
Company Overview
T2 Biosystems, Inc. (TTOO) is a publicly traded company on the NASDAQ exchange. The company specializes in the development of in vitro diagnostics tools for use in laboratories and hospitals. Recently, the company has been promoting its "highly differentiated" products for use in the fight against sepsis.
Technical Analysis
T2 Biosystem's last close was at $0.53 on August 21, 2023, with the highest price for the day at $0.63 and the lowest at $0.51. This indicates a significant downward movement from the day's high. In terms of market capitalization, TTOO is a relatively small entity at $13.08 million with an average volume of 106.45 million, indicating a fairly active trading interest.
TTOO's RSI14 stands at 69, suggesting that the stock is nearing overbought territory. The Moving Average Convergence Divergence (MACD) stands at 0.10, suggesting positive momentum. In terms of moving averages, TTOO is trading above its 50-day moving average ($0.17), but below its 200-day moving average ($0.78), indicating a mixed trend scenario.
Fundamental Analysis
On the fundamental side, it's worth noting that TTOO's earnings per share (EPS) is at a significant negative of $-8.18, and the Price-to-Earnings ratio (PE) stands at $-0.06. This suggests that the company is currently unprofitable and may be perceived as high-risk by traditional investors given its negative profitability metrics.
Recent News and Events
Reviewing recent relevant news, TTOO has announced they will be seeking approval for a reverse stock split in a range between 1-for-50 and 1-for-150 during the annual meeting of stockholders set for September 12. This measure is typically undertaken to boost the stock's price per share, benefiting the company's image, but it does not change the overall value of one's holdings.
There has been recent buzz regarding the company’s stock, similar to the frenzy seen with meme stocks. However, this buzz can lead to high volatility as it is not always linked to the company's fundamentals.
Predictions and Evaluation
Given the company's poor financial health and the imminent reverse stock split, predicting the stock's near-term performance can be challenging. For the next trading day, August 22, 2023, the stock is likely to experience fluctuating prices due to its intrinsic volatility and investor reactions to the marked-down proposal.
Looking at the week ahead, the stock's price is likely to remain volatile and unpredictable, particularly in the run-up to the proposed reverse stock split. The stock might trade between its nearest support and resistance levels of $0.45 and $0.56, respectively.
TTOO is a high-risk stock. The high volatility, along with the firm's weak financial health and upcoming stock split, suggest caution. Therefore, based on the data and recent news, the stock is evaluated as Hold. Investors already holding this stock should monitor the situation closely, while prospective investors are advised to be aware of the potential risks.
